These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10344016)

  • 1. Positron emission tomography (PET) in the evaluation of patients with cancer.
    Godwin HA; Zuger JH
    Trans Am Clin Climatol Assoc; 1999; 110():181-94. PubMed ID: 10344016
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis of colorectal cancer with FDG-PET].
    Uno K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():168-72. PubMed ID: 14574875
    [No Abstract]   [Full Text] [Related]  

  • 3. Oncological applications of FDG PET imaging.
    Delbeke D
    J Nucl Med; 1999 Oct; 40(10):1706-15. PubMed ID: 10520713
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of positron-emission tomography in oncology].
    Strauss LG; Kabelitz D; Kremer B; Lode H; Meinertz T; Sauerbruch T; Sterry W
    Dtsch Med Wochenschr; 1996 Feb; 121(7):207-9. PubMed ID: 8681765
    [No Abstract]   [Full Text] [Related]  

  • 5. Positron emission tomography imaging in melanoma and lymphoma.
    Abella-Columna E; Valk PE
    Semin Roentgenol; 2002 Apr; 37(2):129-39. PubMed ID: 12134366
    [No Abstract]   [Full Text] [Related]  

  • 6. [Positron emission tomography (PET) in clinical oncology. Part II].
    Cabrera Villegas A; Gámez Cenzano C; Martín Urreta JC
    Rev Esp Med Nucl; 2002 Apr; 21(2):131-47; quiz 149-51. PubMed ID: 11879626
    [No Abstract]   [Full Text] [Related]  

  • 7. Positron emission tomography imaging in evaluation of cancer patients.
    Kumar R; Bhargava P; Bozkurt MF; Zhuang H; Potenta S; Alavi A
    Indian J Cancer; 2003; 40(3):87-100. PubMed ID: 14716112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of FDG-PET in oncology.
    Czernin J
    Acta Med Austriaca; 2002; 29(5):162-70. PubMed ID: 12506767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical role of FDG PET in evaluation of cancer patients.
    Kostakoglu L; Agress H; Goldsmith SJ
    Radiographics; 2003; 23(2):315-40; quiz 533. PubMed ID: 12640150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical PET in oncology.
    Biersack HJ; Bender H; Ruhlmann J; Oehr P; Guhlke S; Grünwald F
    Rev Esp Med Nucl; 2000 Jun; 19(3):219-24. PubMed ID: 11062087
    [No Abstract]   [Full Text] [Related]  

  • 11. Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma.
    Kato H; Miyazaki T; Nakajima M; Fukuchi M; Manda R; Kuwano H
    Br J Surg; 2004 Aug; 91(8):1004-9. PubMed ID: 15286962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of positron emission tomography (PET) imaging in disease staging and therapy assessment.
    Jerusalem G; Hustinx R; Beguin Y; Fillet G
    Ann Oncol; 2002; 13 Suppl 4():227-34. PubMed ID: 12401695
    [No Abstract]   [Full Text] [Related]  

  • 13. PET for sarcomas other than gastrointestinal stromal tumors.
    Toner GC; Hicks RJ
    Oncologist; 2008; 13 Suppl 2():22-6. PubMed ID: 18434635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of positron emission tomography with fluorine-18-deoxyglucose in the detection of local recurrent and distant metastatic sarcoma.
    Johnson GR; Zhuang H; Khan J; Chiang SB; Alavi A
    Clin Nucl Med; 2003 Oct; 28(10):815-20. PubMed ID: 14508272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography and colorectal carcinoma: an update.
    Tzimas GN; Koumanis DJ; Meterissian S
    J Am Coll Surg; 2004 Apr; 198(4):645-52. PubMed ID: 15051018
    [No Abstract]   [Full Text] [Related]  

  • 16. Where can FDG-PET contribute most to anatomical imaging problems?
    Bingham JB
    Br J Radiol; 2002 Nov; 75 Spec No():S39-52. PubMed ID: 12519735
    [No Abstract]   [Full Text] [Related]  

  • 17. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
    Salem SS; Shahin MA
    Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET tracers for osteosarcoma.
    Reiman RE
    J Nucl Med; 2004 Aug; 45(8):1424; author reply 1424-5. PubMed ID: 15299071
    [No Abstract]   [Full Text] [Related]  

  • 19. PET scans of abdominal malignancy.
    Blahd WH; Brown CV; Khonsary SA; Farahi JB; Quinones N; Ribe JY; Coyle JJ; Glass EC; Mandelkern MA
    World J Surg; 1996 Feb; 20(2):245-7. PubMed ID: 8661826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new imaging technique for colorectal cancer: positron emission tomography.
    Flamen P; Van Cutsem E; Mortelmans L
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):22-9. PubMed ID: 11049029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.